WHO gives ‘emergency validation’ to Pfizer-BioNTech corona vaccine, calls for equitable global access

By: |
January 01, 2021 8:35 AM

The WHO, together with the GAVI Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI), are spearheading a global effort called COVAX to distribute vaccines to low- and middle-income countries.

world health organisation emergency use authorisation to pfizer vaccineThe COVAX alliance has said it has agreements for nearly 2 billion doses, with first deliveries due in early 2021.

The World Health Organization on Thursday listed the COVID-19 vaccine from Pfizer and BioNTech for emergency use, saying the move opens the door for countries to expedite their own approvals to import and give the shot. Once a vaccine has been listed for WHO emergency use, the United Nations health agency said, it “engages its regional regulatory networks and partners to inform national health authorities on the vaccine and its anticipated benefits based on data from clinical studies to date. “The WHO’s review found that the vaccine met the must-have criteria for safety and efficacy set out by WHO, and that the benefits of using the vaccine to address COVID-19 offset potential risks, the WHO said in a statement.

“This is a very positive step towards ensuring global access to COVID-19 vaccines. But I want to emphasize the need for an even greater global effort to achieve enough vaccine supply to meet the needs of priority populations everywhere,” said Dr Mariangela Simao, WHO assistant-director general for Access to Medicines and Health Products.

The WHO, together with the GAVI Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI), are spearheading a global effort called COVAX to distribute vaccines to low- and middle-income countries, to help make sure that shots do not go only to wealthy nations. The COVAX alliance has said it has agreements for nearly 2 billion doses, with first deliveries due in early 2021.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Had Corona infection? Here’s how you can regain your health post Covid-19
2Govt support necessary to increase penetration of robotic surgery in tier 2, 3 cities: Dr. Sudhir P. Srivastava, SS Innovations
3Maharashtra, UP, Delhi among ten states account for over 71 per cent of new COVID-19 cases